Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
346 | 36072 | 32.2 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
346 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN | 36072 |
1488 | 2 | CAMPTOTHECIN//TOPOISOMERASE I//SN 38 | 7627 |
1654 | 2 | DISTAMYCIN//MINOR GROOVE BINDER//PYRROLE IMIDAZOLE POLYAMIDE | 6885 |
1783 | 2 | SHIKONIN//NAPHTHOQUINONE//PLUMBAGIN | 6353 |
2227 | 2 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN | 4791 |
2252 | 2 | ANGUCYCLINE//IDARUBICIN//ANGUCYCLINONE | 4694 |
2496 | 2 | IFOSFAMIDE//CHEMOSENSITIVITY TEST//MESNA | 3914 |
3321 | 2 | BLEOMYCIN//MIGRASTATIN//BLEOMYCIN HYDROLASE | 1808 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CARDIOTOXICITY | authKW | 448536 | 3% | 52% | 1024 |
2 | ANTHRACYCLINES | authKW | 263303 | 2% | 42% | 739 |
3 | CAMPTOTHECIN | authKW | 224036 | 2% | 45% | 589 |
4 | DOXORUBICIN | authKW | 154668 | 3% | 17% | 1074 |
5 | SHIKONIN | authKW | 153755 | 1% | 82% | 223 |
6 | TOPOISOMERASE I | authKW | 151402 | 1% | 57% | 316 |
7 | TOPOISOMERASE II | authKW | 126778 | 1% | 46% | 326 |
8 | TOPOISOMERASE | authKW | 119591 | 1% | 44% | 322 |
9 | NAPHTHOQUINONE | authKW | 117557 | 1% | 47% | 297 |
10 | PLUMBAGIN | authKW | 106028 | 0% | 74% | 170 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 58254 | 22% | 1% | 7998 |
2 | Pharmacology & Pharmacy | 32302 | 19% | 1% | 7000 |
3 | Chemistry, Medicinal | 31513 | 9% | 1% | 3389 |
4 | Chemistry, Organic | 25458 | 13% | 1% | 4818 |
5 | Biochemistry & Molecular Biology | 12116 | 19% | 0% | 6898 |
6 | Chemistry, Multidisciplinary | 5589 | 11% | 0% | 3968 |
7 | Biophysics | 3263 | 5% | 0% | 1646 |
8 | Toxicology | 2344 | 3% | 0% | 1158 |
9 | Microbiology | 652 | 3% | 0% | 1201 |
10 | Hematology | 505 | 2% | 0% | 723 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL PHARMACOL | 11317 | 1% | 4% | 317 |
2 | PHARMACEUT TECHNOL BIOCHEM | 11138 | 0% | 19% | 72 |
3 | MODIFIED ANTIBIOT | 10883 | 0% | 65% | 20 |
4 | CELL MED | 9390 | 0% | 70% | 16 |
5 | ROCKY MT CANC REHABIL | 9063 | 0% | 51% | 21 |
6 | QUIM SINTET HETEROCICL | 8445 | 0% | 100% | 10 |
7 | HRICHTUNG PHARMAZEUT CHEM | 8389 | 0% | 76% | 13 |
8 | PHARMACOL ANTITUMORALE | 8128 | 0% | 26% | 38 |
9 | DANIEL DEN HOED KLIN | 8087 | 0% | 28% | 34 |
10 | AUCKLAND CANC SOC | 7501 | 0% | 12% | 76 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 83636 | 2% | 12% | 858 |
2 | CANCER TREATMENT REPORTS | 34033 | 1% | 14% | 300 |
3 | JOURNAL OF ANTIBIOTICS | 31589 | 1% | 8% | 505 |
4 | ANTI-CANCER DRUG DESIGN | 30483 | 0% | 24% | 151 |
5 | INVESTIGATIONAL NEW DRUGS | 23692 | 1% | 11% | 270 |
6 | ANTI-CANCER DRUGS | 12951 | 1% | 7% | 227 |
7 | CANCER RESEARCH | 12834 | 2% | 2% | 808 |
8 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 12078 | 0% | 9% | 166 |
9 | BIOCHEMICAL PHARMACOLOGY | 8772 | 1% | 2% | 457 |
10 | BIOORGANIC & MEDICINAL CHEMISTRY | 8079 | 1% | 3% | 366 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARDIOTOXICITY | 448536 | 3% | 52% | 1024 | Search CARDIOTOXICITY | Search CARDIOTOXICITY |
2 | ANTHRACYCLINES | 263303 | 2% | 42% | 739 | Search ANTHRACYCLINES | Search ANTHRACYCLINES |
3 | CAMPTOTHECIN | 224036 | 2% | 45% | 589 | Search CAMPTOTHECIN | Search CAMPTOTHECIN |
4 | DOXORUBICIN | 154668 | 3% | 17% | 1074 | Search DOXORUBICIN | Search DOXORUBICIN |
5 | SHIKONIN | 153755 | 1% | 82% | 223 | Search SHIKONIN | Search SHIKONIN |
6 | TOPOISOMERASE I | 151402 | 1% | 57% | 316 | Search TOPOISOMERASE+I | Search TOPOISOMERASE+I |
7 | TOPOISOMERASE II | 126778 | 1% | 46% | 326 | Search TOPOISOMERASE+II | Search TOPOISOMERASE+II |
8 | TOPOISOMERASE | 119591 | 1% | 44% | 322 | Search TOPOISOMERASE | Search TOPOISOMERASE |
9 | NAPHTHOQUINONE | 117557 | 1% | 47% | 297 | Search NAPHTHOQUINONE | Search NAPHTHOQUINONE |
10 | PLUMBAGIN | 106028 | 0% | 74% | 170 | Search PLUMBAGIN | Search PLUMBAGIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WANG, JC , (1996) DNA TOPOISOMERASES.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 65. ISSUE . P. 635-692 | 402 | 81% | 1741 |
2 | STERBA, M , POPELOVA, O , VAVROVA, A , JIRKOVSKY, E , KOVARIKOVA, P , GERSL, V , SIMUNEK, T , (2013) OXIDATIVE STRESS, REDOX SIGNALING, AND METAL CHELATION IN ANTHRACYCLINE CARDIOTOXICITY AND PHARMACOLOGICAL CARDIOPROTECTION.ANTIOXIDANTS & REDOX SIGNALING. VOL. 18. ISSUE 8. P. 899 -929 | 224 | 82% | 67 |
3 | SCHOEFFLER, AJ , BERGER, JM , (2008) DNA TOPOISOMERASES: HARNESSING AND CONSTRAINING ENERGY TO GOVERN CHROMOSOME TOPOLOGY.QUARTERLY REVIEWS OF BIOPHYSICS. VOL. 41. ISSUE 1. P. 41-101 | 214 | 78% | 204 |
4 | CHAMPOUX, JJ , (2001) DNA TOPOISOMERASES: STRUCTURE, FUNCTION, AND MECHANISM.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 70. ISSUE . P. 369-413 | 147 | 80% | 1421 |
5 | FORTUNE, JM , OSHEROFF, N , (2000) TOPOISOMERASE II AS A TARGET FOR ANTICANCER DRUGS: WHEN ENZYMES STOP BEING NICE.PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 64. VOL. 64. ISSUE . P. 221 -253 | 215 | 90% | 229 |
6 | BAILLY, C , CHAIRES, JB , (1998) SEQUENCE-SPECIFIC DNA MINOR GROOVE BINDERS. DESIGN AND SYNTHESIS OF NETROPSIN AND DISTAMYCIN ANALOGUES.BIOCONJUGATE CHEMISTRY. VOL. 9. ISSUE 5. P. 513 -538 | 223 | 87% | 231 |
7 | CARVALHO, FS , BURGEIRO, A , GARCIA, R , MORENO, AJ , CARVALHO, RA , OLIVEIRA, PJ , (2014) DOXORUBICIN-INDUCED CARDIOTOXICITY: FROM BIOENERGETIC FAILURE AND CELL DEATH TO CARDIOMYOPATHY.MEDICINAL RESEARCH REVIEWS. VOL. 34. ISSUE 1. P. 106 -135 | 142 | 73% | 76 |
8 | POMMIER, Y , (2013) DRUGGING TOPOISOMERASES: LESSONS AND CHALLENGES.ACS CHEMICAL BIOLOGY. VOL. 8. ISSUE 1. P. 82 -95 | 109 | 80% | 188 |
9 | VENDITTO, VJ , SIMANEK, EE , (2010) CANCER THERAPIES UTILIZING THE CAMPTOTHECINS: A REVIEW OF THE IN VIVO LITERATURE.MOLECULAR PHARMACEUTICS. VOL. 7. ISSUE 2. P. 307-349 | 194 | 68% | 108 |
10 | POMMIER, Y , POURQUIER, P , FAN, Y , STRUMBERG, D , (1998) MECHANISM OF ACTION OF EUKARYOTIC DNA TOPOISOMERASE I AND DRUGS TARGETED TO THE ENZYME.BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION. VOL. 1400. ISSUE 1-3. P. 83 -106 | 191 | 78% | 433 |
Classes with closest relation at Level 3 |